Tag: CNS Drug Development

Daniel Lee, MD: Challenge Assumptions, Follow the Evidence, Advance the Science

I’m pleased to share my professional biography, reflecting a career that has taken me from military medicine and psychiatry to the FDA, global pharmaceutical clinical development, scientific research, and independent consulting. Throughout that journey, I have remained committed to rigorous science, transparent and ethical leadership, and advancing innovative treatments that can make a meaningful difference for patients, particularly across CNS and psychiatric conditions. As I continue exploring opportunities to contribute at the board and advisory level, I look forward to bringing these experiences to organizations navigating complex scientific, clinical, regulatory, and strategic challenges.